Thomas S. Liang

Rapid HIV Testing of Clients of a Mobile STD/HIV Clinic

Thomas S. Liang, Emily J. Erbelding, Claude A. Jacob et al. · AIDS Patient Care and STDs · 2005 · 107 citations

Public Health, Infectious Disease Control, Preventive Medicine +17

Serum Amyloid A Is a Chemotactic Agonist at FPR2, a Low-Affinity N-Formylpeptide Receptor on Mouse Neutrophils

Thomas S. Liang, Jiming Wang, Philip M. Murphy et al. · Biochemical and Biophysical Research Communications · 2000 · 96 citations

Life Sciences, Immunology, Pharmacology +11

Assessing the Attitudes, Knowledge, and Awareness of HIV Vaccine Research Among Adults in the United States

Mary Allen, Thomas S. Liang, Thomas La Salvia et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 49 citations

Public Health, Population Health Sciences, Preventive Medicine +17

The HIV-1 Cell Entry Inhibitor T-20 Potently Chemoattracts Neutrophils by Specifically Activating the N-Formylpeptide Receptor

Jennifer K. Hartt, Thomas S. Liang, Alfredo Sahagún-Ruiz et al. · Biochemical and Biophysical Research Communications · 2000 · 36 citations

Life Sciences, Cell Biology, Immunology +11

The Endogenous Opioid Spinorphin Blocks fMet-Leu-Phe-Induced Neutrophil Chemotaxis by Acting as a Specific Antagonist at the <i>N</i> -Formylpeptide Receptor Subtype FPR

Thomas S. Liang, Ji‐Liang Gao, Omid Fatemi et al. · The Journal of Immunology · 2001 · 34 citations · Full text

Medicine, Neurobiology, Pharmacology +17